IBDEI1LW ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27254,1,3,0)
 ;;=3^HTN Hrt Disease w/o Hrt Failure and CKD, Stage 1-4
 ;;^UTILITY(U,$J,358.3,27254,1,4,0)
 ;;=4^I13.10
 ;;^UTILITY(U,$J,358.3,27254,2)
 ;;=^5007068
 ;;^UTILITY(U,$J,358.3,27255,0)
 ;;=I13.11^^106^1345^12
 ;;^UTILITY(U,$J,358.3,27255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27255,1,3,0)
 ;;=3^HTN Hrt Disease w/o Hrt Failure and CKD,Stage 5 or ESRD
 ;;^UTILITY(U,$J,358.3,27255,1,4,0)
 ;;=4^I13.11
 ;;^UTILITY(U,$J,358.3,27255,2)
 ;;=^5007069
 ;;^UTILITY(U,$J,358.3,27256,0)
 ;;=I50.1^^106^1345^15
 ;;^UTILITY(U,$J,358.3,27256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27256,1,3,0)
 ;;=3^Left Ventricular Failure
 ;;^UTILITY(U,$J,358.3,27256,1,4,0)
 ;;=4^I50.1
 ;;^UTILITY(U,$J,358.3,27256,2)
 ;;=^5007238
 ;;^UTILITY(U,$J,358.3,27257,0)
 ;;=E21.3^^106^1346^17
 ;;^UTILITY(U,$J,358.3,27257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27257,1,3,0)
 ;;=3^Hyperparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,27257,1,4,0)
 ;;=4^E21.3
 ;;^UTILITY(U,$J,358.3,27257,2)
 ;;=^331438
 ;;^UTILITY(U,$J,358.3,27258,0)
 ;;=E78.5^^106^1346^16
 ;;^UTILITY(U,$J,358.3,27258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27258,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,27258,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,27258,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,27259,0)
 ;;=M10.30^^106^1346^11
 ;;^UTILITY(U,$J,358.3,27259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27259,1,3,0)
 ;;=3^Gout d/t Renal Impairment,Unspec Site
 ;;^UTILITY(U,$J,358.3,27259,1,4,0)
 ;;=4^M10.30
 ;;^UTILITY(U,$J,358.3,27259,2)
 ;;=^5010356
 ;;^UTILITY(U,$J,358.3,27260,0)
 ;;=E66.9^^106^1346^33
 ;;^UTILITY(U,$J,358.3,27260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27260,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,27260,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,27260,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,27261,0)
 ;;=E66.01^^106^1346^32
 ;;^UTILITY(U,$J,358.3,27261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27261,1,3,0)
 ;;=3^Obesity,Morbid,d/t Excess Calories
 ;;^UTILITY(U,$J,358.3,27261,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,27261,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,27262,0)
 ;;=D50.9^^106^1346^2
 ;;^UTILITY(U,$J,358.3,27262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27262,1,3,0)
 ;;=3^Anemia,Iron Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,27262,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,27262,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,27263,0)
 ;;=D63.1^^106^1346^1
 ;;^UTILITY(U,$J,358.3,27263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27263,1,3,0)
 ;;=3^Anemia in Chronic Kidney Disease
 ;;^UTILITY(U,$J,358.3,27263,1,4,0)
 ;;=4^D63.1
 ;;^UTILITY(U,$J,358.3,27263,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,27264,0)
 ;;=G60.9^^106^1346^31
 ;;^UTILITY(U,$J,358.3,27264,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27264,1,3,0)
 ;;=3^Neuropathy,Hereditary/Idiopathic,Unspec
 ;;^UTILITY(U,$J,358.3,27264,1,4,0)
 ;;=4^G60.9
 ;;^UTILITY(U,$J,358.3,27264,2)
 ;;=^5004071
 ;;^UTILITY(U,$J,358.3,27265,0)
 ;;=I73.9^^106^1346^34
 ;;^UTILITY(U,$J,358.3,27265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27265,1,3,0)
 ;;=3^PVD,Unspec
 ;;^UTILITY(U,$J,358.3,27265,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,27265,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,27266,0)
 ;;=N04.9^^106^1346^30
 ;;^UTILITY(U,$J,358.3,27266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27266,1,3,0)
 ;;=3^Nephrotic Syndrome w/ Unspec Morphologic Changes
 ;;^UTILITY(U,$J,358.3,27266,1,4,0)
 ;;=4^N04.9
 ;;^UTILITY(U,$J,358.3,27266,2)
 ;;=^5015540
 ;;^UTILITY(U,$J,358.3,27267,0)
 ;;=N25.0^^106^1346^35
